Biomarin Pharmaceutical Financials

Values in thousands	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Revenue	$766,208	$874,565	$776,133	$825,410
Gross Profit	571,209	579,470	636,048	675,320
EBITDA	172,572	-3,937	-5,258	319,110
EBIT	156,161	-24,375	-23,745	300,547
Net Income	105,527	-46,573	-30,744	240,532
Net Change In Cash	766,208	874,565	776,133	825,410
Free Cash Flow	199,728	58,922	340,238	168,170
Cash	2,222,435	1,311,679	1,250,108	1,213,816
Basic Shares	197,671	197,394	192,032	196,643

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$3,221,253	$2,853,915	$2,419,226	$2,096,039
Gross Profit	2,484,425	2,273,680	1,887,164	1,593,016
EBITDA	572,936	650,528	306,773	265,359
EBIT	493,379	554,102	202,387	163,390
Net Income	348,901	426,859	167,645	141,561
Net Change In Cash	3,221,253	2,853,915	2,419,226	2,096,039
Free Cash Flow	724,956	475,423	62,568	54,943
Cash	1,311,679	942,842	755,127	724,531
Basic Shares	197,394	196,708	191,595	188,963